FUSION PHARMACEUTICALS
FUSN Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2024-06-04
2024-06-04
BURAK ERIC
Chief Technology Officer
D - Sale to Issuer
Restricted Stock Units
-63,700
1
$207.99M
2024-06-04
2024-06-04
VALLIANT JOHN
Chief Executive Officer
D - Sale to Issuer
Restricted Stock Units
-192K
1
$207.99M
2024-06-04
2024-06-04
RAWAT MOHIT
President & CBO
D - Sale to Issuer
Stock Option (Right to Buy)
-770K
4
$207.99M
2024-06-04
2024-06-04
VALLIANT JOHN
Chief Executive Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-3.73M
10
$207.99M
2024-06-04
2024-06-04
VALLIANT JOHN
Chief Executive Officer
D - Sale to Issuer
Common Stock
-318K
1
$207.99M
2024-06-04
2024-06-04
BERGSTROM DONALD
D - Sale to Issuer
Stock Option (Right to Buy)
-85,000
4
$207.99M
2024-06-04
2024-06-04
BITETTI TERESA MARIE
D - Sale to Issuer
Stock Option (Right to Buy)
-34,000
1
$207.99M
2024-06-04
2024-06-04
BOBILEV DMITRI
Chief Medical Officer
D - Sale to Issuer
Restricted Stock Units
-91,000
1
$207.99M
2024-06-04
2024-06-04
BOBILEV DMITRI
Chief Medical Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-702K
2
$207.99M
2024-06-04
2024-06-04
BURAK ERIC
Chief Technology Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-1.26M
13
$207.99M
2024-06-04
2024-06-04
BURAK ERIC
Chief Technology Officer
D - Sale to Issuer
Common Stock
-38,490
1
$207.99M
2024-06-04
2024-06-04
CROWLEY JOHN
Chief Financial Officer
D - Sale to Issuer
Restricted Stock Units
-63,700
1
$207.99M
2024-06-04
2024-06-04
CROWLEY JOHN
Chief Financial Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-1.10M
8
$207.99M
2024-06-04
2024-06-04
CROWLEY JOHN
Chief Financial Officer
D - Sale to Issuer
Common Stock
-10,410
1
$207.99M
2024-06-04
2024-06-04
DUNCAN BARBARA GAYLE
D - Sale to Issuer
Stock Option (Right to Buy)
-81,000
4
$207.99M
2024-06-04
2024-06-04
LEAMON CHRISTOPHER
Chief Scientific Officer
D - Sale to Issuer
Restricted Stock Units
-63,700
1
$207.99M
2024-06-04
2024-06-04
LEAMON CHRISTOPHER
Chief Scientific Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-574K
3
$207.99M
2024-06-04
2024-06-04
LEAMON CHRISTOPHER
Chief Scientific Officer
D - Sale to Issuer
Common Stock
-11,957
1
$207.99M
2024-06-04
2024-06-04
RAWAT MOHIT
President & CBO
D - Sale to Issuer
Restricted Stock Units
-81,300
1
$207.99M
2024-01-04
2024-01-05
CROWLEY JOHN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
106K
$0.00
1
$207.99M
2024-01-04
2024-01-05
LEAMON CHRISTOPHER
Chief Scientific Officer
A - Grant
Restricted Stock Units
63,700
$0.00
1
$207.99M
2024-01-04
2024-01-05
LEAMON CHRISTOPHER
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
106K
$0.00
1
$207.99M
2024-01-04
2024-01-05
RAWAT MOHIT
President & CBO
A - Grant
Restricted Stock Units
81,300
$0.00
1
$207.99M
2024-01-04
2024-01-05
RAWAT MOHIT
President & CBO
A - Grant
Stock Option (Right to Buy)
136K
$0.00
1
$207.99M
2024-01-04
2024-01-05
VALLIANT JOHN
Chief Executive Officer
A - Grant
Restricted Stock Units
192K
$0.00
1
$207.99M
2024-01-04
2024-01-05
VALLIANT JOHN
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
320K
$0.00
1
$207.99M
2024-01-04
2024-01-05
BOBILEV DMITRI
Chief Medical Officer
A - Grant
Restricted Stock Units
91,000
$0.00
1
$207.99M
2024-01-04
2024-01-05
BOBILEV DMITRI
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
152K
$0.00
1
$207.99M
2024-01-04
2024-01-05
BURAK ERIC
Chief Technology Officer
A - Grant
Restricted Stock Units
63,700
$0.00
1
$207.99M
2024-01-04
2024-01-05
BURAK ERIC
Chief Technology Officer
A - Grant
Stock Option (Right to Buy)
106K
$0.00
1
$207.99M
2024-01-04
2024-01-05
CROWLEY JOHN
Chief Financial Officer
A - Grant
Restricted Stock Units
63,700
$0.00
1
$207.99M
2023-08-31
2024-01-05
LEAMON CHRISTOPHER
Chief Scientific Officer
A - Grant
Common Stock
11,957
1
$207.99M
2023-10-16
2023-10-16
BITETTI TERESA MARIE
A - Grant
Stock Option (Right to Buy)
34,000
$0.00
1
$207.99M
2023-01-05
2023-01-09
BURAK ERIC
Chief Technology Officer
A - Grant
Stock Option (Right to Buy)
250K
$0.00
1
$207.99M
2023-01-05
2023-01-09
CROWLEY JOHN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
250K
$0.00
1
$207.99M
2023-01-05
2023-01-09
VALLIANT JOHN
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
500K
$0.00
1
$207.99M
2023-01-05
2023-01-09
LEAMON CHRISTOPHER
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
250K
$0.00
1
$207.99M
2023-01-05
2023-01-09
RAWAT MOHIT
President and CBO
A - Grant
Stock Option (Right to Buy)
300K
$0.00
1
$207.99M
2022-11-07
2022-11-07
BOBILEV DMITRI
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
550K
$0.00
1
$207.99M
2022-04-27
2022-04-27
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-4,511
$6.00
-27,066
1
$207.99M
2022-04-26
2022-04-27
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-2,147
$6.00
-12,882
1
$207.99M
2022-04-25
2022-04-27
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-2,036
$6.00
-12,216
1
$207.99M
2022-04-21
2022-04-22
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-922
$6.00
-5,532
1
$207.99M
2022-04-20
2022-04-22
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-367
$6.00
-2,202
1
$207.99M
2022-04-13
2022-04-13
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-11,994
$6.00
-71,964
1
$207.99M
2022-04-12
2022-04-13
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-18,255
$7.00
-128K
1
$207.99M
2022-04-11
2022-04-13
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-2,600
$7.00
-18,200
1
$207.99M
2022-04-08
2022-04-08
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-826
$8.00
-6,608
1
$207.99M
2022-04-07
2022-04-08
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-1,255
$8.00
-10,040
1
$207.99M
2022-04-06
2022-04-08
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-100
$8.00
-800
1
$207.99M
2022-04-05
2022-04-05
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-2,100
$8.00
-16,800
1
$207.99M
2022-04-04
2022-04-05
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-700
$8.00
-5,600
1
$207.99M
2022-04-01
2022-04-05
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-1,000
$8.00
-8,000
1
$207.99M
2022-03-30
2022-04-01
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-300
$8.00
-2,400
1
$207.99M
2022-03-29
2022-03-29
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-200
$8.00
-1,600
1
$207.99M
2022-03-28
2022-03-29
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-9,600
$8.00
-76,800
1
$207.99M
2022-03-25
2022-03-29
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-500
$7.00
-3,500
1
$207.99M
2022-03-23
2022-03-24
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-100
$8.00
-800
1
$207.99M
2022-03-22
2022-03-24
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-4,000
$8.00
-32,000
1
$207.99M
2022-03-21
2022-03-24
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-700
$7.00
-4,900
1
$207.99M
2022-03-21
2022-03-21
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-1,500
$7.00
-10,500
1
$207.99M
2022-03-18
2022-03-21
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-1,204
$8.00
-9,632
1
$207.99M
2022-03-17
2022-03-21
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-900
$8.00
-7,200
1
$207.99M
2022-03-16
2022-03-16
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-100
$7.00
-700
1
$207.99M
2022-03-15
2022-03-16
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-100
$7.00
-700
1
$207.99M
2022-03-14
2022-03-16
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-1,300
$7.00
-9,100
1
$207.99M
2022-03-11
2022-03-14
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-100
$7.00
-700
1
$207.99M
2022-03-10
2022-03-14
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-1,900
$7.00
-13,300
1
$207.99M
2022-03-09
2022-03-14
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-822
$7.00
-5,754
1
$207.99M
2022-03-08
2022-03-08
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-3,004
$7.00
-21,028
1
$207.99M
2022-03-07
2022-03-08
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-3,100
$7.00
-21,700
1
$207.99M
2022-03-04
2022-03-08
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-8,400
$7.00
-58,800
1
$207.99M
2022-03-03
2022-03-03
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-200
$7.00
-1,400
1
$207.99M
2022-03-02
2022-03-03
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-26,546
$7.00
-186K
1
$207.99M
2022-03-01
2022-03-03
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-847
$7.00
-5,929
1
$207.99M
2022-02-28
2022-02-28
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-3,100
$7.00
-21,700
1
$207.99M
2022-02-25
2022-02-28
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-8,152
$8.00
-65,216
1
$207.99M
2022-02-24
2022-02-28
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-2,500
$7.00
-17,500
1
$207.99M
2022-02-23
2022-02-23
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-29,299
$8.00
-234K
1
$207.99M
2022-02-22
2022-02-23
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-4,100
$8.00
-32,800
1
$207.99M
2022-02-18
2022-02-23
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-4,898
$8.00
-39,184
1
$207.99M
2022-02-17
2022-02-17
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-1,700
$8.00
-13,600
1
$207.99M
2022-02-16
2022-02-17
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-33,202
$8.00
-266K
1
$207.99M
2022-02-15
2022-02-17
VALLIANT JOHN
Chief Executive Officer
S - Sale
Common Stock
-12,600
$8.00
-101K
1
$207.99M
2022-02-01
2022-02-03
O'LEARY JAMES
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
159K
$0.00
1
$207.99M
2022-02-01
2022-02-03
VALLIANT JOHN
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
407K
$0.00
1
$207.99M
2022-02-01
2022-02-03
BURAK ERIC
Chief? Scientific Officer
A - Grant
Stock Option (Right to Buy)
168K
$0.00
1
$207.99M
2022-02-01
2022-02-03
CROWLEY JOHN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
167K
$0.00
1
$207.99M
2022-02-01
2022-02-03
RAWAT MOHIT
President and CBO
A - Grant
Stock Option (Right to Buy)
77,900
$0.00
1
$207.99M
2021-11-01
2021-11-02
LEAMON CHRISTOPHER
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
218K
$0.00
1
$207.99M
2021-09-27
2021-09-30
RAWAT MOHIT
President and CBO
A - Grant
Stock Option (Right to Buy)
257K
$0.00
1
$207.99M
2021-02-04
2021-02-08
BURAK ERIC
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
317K
$0.00
3
$207.99M
2021-02-04
2021-02-08
CROWLEY JOHN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
138K
$0.00
1
$207.99M
2021-02-04
2021-02-08
O'LEARY JAMES
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
114K
$0.00
1
$207.99M
2021-02-04
2021-02-08
VALLIANT JOHN
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
336K
$0.00
1
$207.99M
2020-10-30
2020-11-03
DUNCAN BARBARA GAYLE
A - Grant
Stock Option (Right to Buy)
30,000
$0.00
1
$207.99M
2020-06-30
2020-07-02
HEALTHCAP VII, L.P.
C - Conversion
Class A Preferred Exchangeable Shares
-13M
1
$207.99M
2020-06-30
2020-07-02
ADAMS STREET PARTNERS LLC
C - Conversion
Class B Preferred Shares
-5.37M
5
$207.99M
2020-06-30
2020-07-02
CROWLEY JOHN
Chief Financial Officer
P - Purchase
Common Stock
6,500
$17.00
111K
1
$207.99M
2020-06-30
2020-07-02
O'LEARY JAMES
Chief Medical Officer
P - Purchase
Common Stock
300
$17.00
5,100
1
$207.99M
2020-06-30
2020-07-02
TPG GROUP HOLDINGS (SBS) ADVISORS, INC.
P - Purchase
Common Stock
250K
$17.00
4.25M
1
$207.99M
2020-06-30
2020-07-02
ADAMS STREET PARTNERS LLC
C - Conversion
Class A Preferred Shares
-13M
5
$207.99M
2020-06-30
2020-07-02
CHRISTENSON JOHAN
C - Conversion
Class A Preferred Exchangeable Shares
-13M
1
$207.99M
2020-06-30
2020-07-02
CHRISTENSON JOHAN
C - Conversion
Class B Preferred Exchangeable Shares
-5.71M
1
$207.99M
2020-06-30
2020-07-02
HEALTHCAP VII, L.P.
C - Conversion
Class B Preferred Exchangeable Shares
-5.71M
1
$207.99M
2020-06-30
2020-07-02
JOHNSON JOHNSON
C - Conversion
Warrants to purchase Common Shares
89,118
$0.00
1
$207.99M
2020-06-30
2020-07-02
JOHNSON JOHNSON
C - Conversion
Warrants to purchase Class B Preferred Shares
-476K
$0.00
1
$207.99M
2020-06-30
2020-07-02
TPG GROUP HOLDINGS (SBS) ADVISORS, INC.
C - Conversion
Class A Preferred Shares
-8.00M
1
$207.99M
2020-06-30
2020-07-02
TPG GROUP HOLDINGS (SBS) ADVISORS, INC.
C - Conversion
Class B Preferred Shares
-4.29M
1
$207.99M
2020-06-30
2020-07-02
TPG GROUP HOLDINGS (SBS) ADVISORS, INC.
C - Conversion
Common Stock
2.30M
$0.00
1
$207.99M
2020-06-30
2020-07-02
VARIAN MEDICAL SYSTEMS INC
C - Conversion
Class A Preferred Shares
-2.67M
1
$207.99M
2020-06-30
2020-07-02
VARIAN MEDICAL SYSTEMS INC
C - Conversion
Class B Preferred Shares
-15M
1
$207.99M
2020-06-25
2020-06-30
VALLIANT JOHN
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
579K
$0.00
2
$207.99M
2020-06-25
2020-06-30
BURAK ERIC
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
115K
$0.00
2
$207.99M
2020-06-25
2020-06-30
CROWLEY JOHN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
87,824
$0.00
2
$207.99M
2020-06-25
2020-06-30
O'LEARY JAMES
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
87,823
$0.00
2
$207.99M
2020-06-02
2020-06-30
CHRISTENSON JOHAN
P - Purchase
Class B Preferred Exchangeable Shares
2.86M
$1.00
2.86M
1
$207.99M
2020-06-02
2020-06-30
KHUONG CHAU QUANG
P - Purchase
Class B Preferred Shares
5.94M
$1.00
5.94M
1
$207.99M
2020-03-16
2020-06-30
O'LEARY JAMES
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
352K
$0.00
1
$207.99M
2020-02-06
2020-06-30
BURAK ERIC
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
38,561
$0.00
1
$207.99M
2020-02-06
2020-06-30
CROWLEY JOHN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
38,561
$0.00
1
$207.99M
2020-02-06
2020-06-30
VALLIANT JOHN
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
174K
$0.00
1
$207.99M
2020-01-10
2020-06-30
KHUONG CHAU QUANG
A - Grant
Warrants to Purchase Class B Preferred Shares
359K
$0.00
1
$207.99M
2020-01-10
2020-06-30
CHRISTENSON JOHAN
A - Grant
Warrants to purchase Class B Preferred Exchangeable Shares
576K
$0.00
1
$207.99M